12.07.2015 Views

Conference Program - ABRF 2011 - Association of Biomolecular ...

Conference Program - ABRF 2011 - Association of Biomolecular ...

Conference Program - ABRF 2011 - Association of Biomolecular ...

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Poster AbstractsProteomics Core Facility. The data is processed and students examinetheir results and use bioinformatics tools to further understand thebiological implications <strong>of</strong> the results. The students than present theirfindings, describe specific proteins that showed differential expression.A hypothesis is presented explaining the biological relevance <strong>of</strong> theprotein expression change along with a plan for testing this hypothesis.This work was sponsored by Grant Number P20 RR16462, from theIDeA Networks <strong>of</strong> Biomedical Research Excellence (INBRE) <strong>Program</strong> <strong>of</strong>the National Center for Research Resources (NCRR), a component <strong>of</strong>the National Institutes <strong>of</strong> Health (NIH).186 Quantitative Western Blotting withAmersham ECL PrimeM. Winkvist, S. Grimsby, K. Söderquist,A. MarcussonGE Healthcare Bio-Sciences AB, Uppsala, SwedenWestern blotting is a well established technique used to study proteinsfrom a wide variety <strong>of</strong> sources. The technique is used throughout thelife sciences from basic research to medical diagnostic applications.Western Blot is at best considered as semi-quantitative and hencelimited to studies involving large protein differences.Here wedemonstrate the use <strong>of</strong> a new ECL TM reagent, Amersham TM ECL Primein a number <strong>of</strong> typical Western Blotting applications. The resultsdemonstrate that, Amersham ECL Prime can be used for detection <strong>of</strong>low abundant proteins, that signals are very stable over time and covera broad dynamic range. These features make Amersham ECL Primehighly suitable for accurate quantitative analysis.187 New Approaches to QuantitativeWestern BlottingM. Winkvist, Å. Hagner-McWhirter,K. Söderquist, S. GrimsbyGE Healthcare Bio-Sciences AB, Uppsala, SwedenFluorescent detection in Western blotting <strong>of</strong>fers high sensitivity, broaddynamic range and stability <strong>of</strong> signals. This makes it highly suitable forquantitative Western blotting. Here we show how fluorescent Westernblotting can be used for simultaneously detection <strong>of</strong> up to threedifferent proteins on the same blot at the same time and for detection<strong>of</strong> proteins <strong>of</strong> the same molecular weight without stripping and reprobing.We also demonstrate how fluorescent Western blotting with3 layer probing can be used to increase sensitivity and thereby enablesdetection <strong>of</strong> very low abundant proteins. Finally we demonstrate thatit is possible to compare the total protein amount to the target proteinby using Deep Purple TM protein staining prior to ECLTM Plex TM Westernblotting.188 Rubicon PicoPlex-NGS Kits Availablefor Sequencing Single Cells Using theIllumina Genome AnalyzerJ. Langmore, T. Kurihara, E. Kamberov,J. M’Mwirichia, T. Tesmer, D. OldfieldRubicon Genomics, Ann Arbor, MI, United StatesRubicon Genomics has released its PicoPlex-NGS kits to prepare singlecells for NGS analysis on the Illumina Genome Analyzer. These kitsenable single eukaryotic or prokaryotic cells to be lysed, DNA extractedand amplified, and adapted for paired-end sequencing in a 1-tube,3-hr, 4-step process. Although the read coverage is poor in a single lane,the reproducibility <strong>of</strong> the reads allows single cells to be compared forSNP and CNV genotype, mutations. The same amplified samples canbe used for PCR and microarray analysis, including genome-wide SNPgenotyping, mutation, and copy number analysis. PRC amplification ortarget enrichment can be used for high accuracy and coverage singlecellgenomic analysis.189 PRG-<strong>2011</strong>: Defining the InteractionBetween Users and Suppliers <strong>of</strong>Proteomics Services/FacilitiesD.H. Hawke 1 , T.M. Andacht 2 , M.K. Bunger 3 ,C.E. Bystrom 4 , L.J. Dangott 5 , H. Molina 6 ,R.L. Moritz 7 , R.E. Settlage 8 , C.W. Turck 91University <strong>of</strong> Texas MD Anderson Cancer Center,Houston, TX, United States; 2 Centers for DiseaseControl and Prevention, Atlanta, GA, UnitedStates; 3 RTI International, Research TrianglePark, NC, United States; 4 Quest Diagnostics, SanJuan Capistrano, CA, United States; 5 Texas A&MUniversity, College Station, TX, United States;6Center for Genome Regulation, Barcelona,Spain; 7 Institute for Systems Biology, Seattle, WA,United States; 8 Virginia Bioinformatics Institute,Blacksburg, VA, United States; 9 Max Planck Institute<strong>of</strong> Psychiatry, Munich, GermanyOver the last ten years the Proteomics Research Group (PRG) hasundertaken technical studies that have covered a wide range <strong>of</strong> issuesunique to the rapidly developing field <strong>of</strong> proteomics. These studieshaveincluded a range <strong>of</strong> qualitative and quantitative experiments. The PRGstudies have resulted in a great deal <strong>of</strong> attention not only within the<strong>ABRF</strong> community but also outside as is evident from numerous articlesdealing with proteomics methods, procedures and standardization.As the field continues to develop, the diversity <strong>of</strong> instrumentationand laboratory workflows have grown in tandem. Therefore, for thePRG<strong>2011</strong> study it seemed especially useful to perform a survey tohelp define future studies based on the current blend <strong>of</strong> sample typesand technologies and obtain a view <strong>of</strong> emerging trends. A survey wascreated to ascertain three main insights into core facility function: 1)How labs interact with their clients, 2) The capacity <strong>of</strong> labs to meet thedemands <strong>of</strong> their clients, and 3) The blend <strong>of</strong> experimental techniques<strong>of</strong>fered to and requested by clients. Survey questions were designed toobtain information from both users <strong>of</strong> core facilities and the directorsand personnel <strong>of</strong> core facilities. Questions covered such topics as thetype and age <strong>of</strong> instruments in use, how data is analyzed and presentedto client, sources <strong>of</strong> funding, and emerging proteomics trends. Resultsare compiled en masse and presented without regard to institution.190 GlycoMaster — S<strong>of</strong>tware forGlycopeptide Identification withCombined ETD and CID/HCD SpectraP. Shan, L. XinBioinformatics Solutions Inc., Waterloo, ON,CanadaObjective: To automate the data analysis for the identification <strong>of</strong>glycopeptides with combined ETD and CID/HCD fragmentation. Theinputs for GlycoMaster s<strong>of</strong>tware include the raw mass spectrometry84 • <strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!